Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mesenchymal Stromal Cells Improve Islet β-Cell Functional Survival: Analysis of Extracellular Vesicle-Trafficked Proteins and miRNAs.

Cells·2026

Same author

NAMPT activity plays a key role in driving autoimmune processes that mediate beta-cell death and type 1 diabetes development in mice.

Cell death & disease·2026

Same author

A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeae.

Nature microbiology·2026

Same author

Annexin A1 exacerbates islet stellate cell activation by regulating triglyceride catabolism via the PPARα/ACOX1/CYP4a pathway.

Islets·2026

Same author

Role of collagen type III/ITGB1 signalling in stellate cell-mediated regulation of β-cell survival and insulin secretion in the pancreatic islet microenvironment.

Diabetic medicine : a journal of the British Diabetic Association·2026

Same author

Descriptions of intestinal worms in European medieval medical texts.

Parasitology·2025

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Cell-based treatments for diabetes.

Peter M Jones¹, Monica L Courtney, Christopher J Burns

¹Beta Cell Group, Division of Reproduction and Endocrinology, King's College London, London SE1 1UL, UK. peter.jones@kcl.ac.uk

Drug Discovery Today

|July 26, 2008

Summary

This summary is machine-generated.

Type 1 diabetes mellitus involves autoimmune destruction of insulin-producing beta-cells. Cell replacement therapy using stem cells, particularly embryonic stem cells, shows promise for treating this condition due to their potential for large-scale production.

Related Experiment Videos

Last Updated: Jul 3, 2026

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Area of Science:

Endocrinology
Immunology
Regenerative Medicine

Background:

Type 1 diabetes mellitus results from autoimmune destruction of pancreatic beta-cells.
Cell replacement therapy offers a potential cure for Type 1 diabetes.
Limited availability of donor islets restricts current islet transplantation success.

Purpose of the Study:

To explore alternative cell sources for transplantation in Type 1 diabetes.
To evaluate the therapeutic potential of xenografts, tissue stem cells, and embryonic stem cells.
To identify scalable solutions for cell replacement therapy.

Main Methods:

Review of experimental studies on alternative transplant tissues.
Analysis of insulin-expressing cell derivation from various stem cell populations.
Assessment of therapeutic potential and clinical applicability of different cell sources.

Main Results:

Xenografts are closest to clinical application but face significant obstacles.
Insulin-expressing cells can be derived from multiple stem cell types.
Embryonic stem cells offer the potential for vast cell numbers required for therapy.

Conclusions:

Embryonic stem cells represent a promising source for scalable cell replacement therapy in Type 1 diabetes.
Continued research is needed to overcome challenges associated with alternative cell sources.
Cell replacement therapy holds significant potential for curing Type 1 diabetes.